# Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium
> **Food and Drug Administration** · Final rule. · Published 1998-11-03 · Effective 1998-11-03 · 63 FR 59215
## Document
- **Document number:** 98-29332
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 59215
- **CFR reference:** 21 CFR 510
- **Publication date:** 1998-11-03
- **Effective date:** 1998-11-03
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for equine use of hyaluronate sodium injection containing 11 milligrams hyaluronate sodium per milliliter (mg/mL) rather than the currently approved 10 mg/mL.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/11/03/98-29332/implantation-or-injectable-dosage-form-new-animal-drugs-hyaluronate-sodium)
---
*AI Analytics · CC0 1.0*